+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5893822
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Glycated Albumin Assay Market size was estimated at USD 217.29 million in 2023, USD 232.69 million in 2024, and is expected to grow at a CAGR of 7.51% to reach USD 360.92 million by 2030.

The glycated albumin assay is a diagnostic test used to measure the amount of glycated albumin in the blood. Glycated albumin is a form of albumin, which is an abundant protein in human blood plasma and has bonded with glucose. It facilitates rapid adjustments in diabetes management strategies, potentially leading to better short-term control of blood glucose levels.

It offers an alternative for people for whom HbA1c tests might not be accurate, such as those with hemoglobinopathies, recent blood transfusion recipients, or individuals with chronic kidney or liver diseases. The prevalence of diabetes and rising public awareness about monitoring and controlling blood glucose necessitates accurate and reliable testing methods.

However, various countries' reimbursement policies and regulatory frameworks may hinder the widespread use of glycated albumin assays. Expanding healthcare infrastructure in emerging economies provides more significant access to advanced diagnostics tools such as glycated albumin assays, and research into novel biomarkers for glucose regulation is expected to create opportunities for growth of the glycated albumin assay market.

Regional Insights

The Americas represents a significant landscape in the glycated albumin assay market owing to a substantial need for glycated albumin assay due to the high prevalence of diabetes in these countries. Additionally, countries have advanced healthcare systems that can support the adoption of innovative diagnostic tools such as glycated albumin assays. The growing aging population in Europe contributes significantly to the increasing need for advanced diagnostics such as glycated albumin assays. EU countries have comprehensive healthcare systems that prioritize early detection of diseases such as diabetes, increasing the glycated albumin assay need in the region.

In the Middle East and Africa region, there has been a steady rise in lifestyle-related diseases, including diabetes, due to changing demographics and urbanization. Various programs, initiatives, and investments by legal authorities promoted the adoption of innovative diagnostic techniques in the region. The Asia-Pacific market for glycated albumin assay is expanding rapidly due to the growing prevalence of diabetes, increasing research and development activities, and significant advancements in developing novel techniques for glycated albumin detection.

Market Trends by Segment

  • Product: Increasing use of animal glycated albumin assay to understand disease mechanisms
  • Application: Significant adoption of glycated albumin assay for detection of type 1 diabetes owing to prevent health complications
  • End User: High usage of glycated albumin assay in diagnostic laboratories

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Pioneering Partnership Between John Lewis and Randox Unveils In-Store Blood Testing to Enhance Health Diagnostics

John Lewis joined forces with the diagnostic innovator Randox to introduce in-store blood testing services, marking a significant leap towards convenience in health and wellness. This collaboration, the first in department stores, aims to diminish NHS waiting lists by offering comprehensive health checks for various cancers, diabetes, and heart disease. Leveraging Randox's cutting-edge lab-on-a-chip technology, the partnership seeks to revolutionize cancer diagnostics, potentially reducing invasive procedures and alleviating NHS burdens with savings projected to be around GBP 3 billion annually. This service expansion into genetic testing and checks for vitamin deficiencies underlines a move toward personalized, preventative care.

Strategic Initiatives to Combat Diabetes and Hypertension in India

The West Bengal State Health Department announced efforts to manage diabetes and hypertension. To incorporate 7.5 million adults into standardized medical care by 2025, the initiative aims to reverse the oversight of these conditions during the COVID-19 pandemic. Specifically, Kolkata seeks to extend care to over 400,000 patients by December 2025. This nationwide campaign involves comprehensive screening efforts, early diagnosis, and timely intervention strategies, particularly targeting adults above 30 through free blood pressure and glucose screenings. These screenings are available at hospitals and community camps, with display signs at critical hospital locations such as OPD ticket counters, encouraging participation.

Advancing Type 1 Diabetes Care: Enable Biosciences Launches Innovative 'Kit to Clinics' Program Featuring ADAP Technology

Enable Biosciences Inc. rolled out its Kit to Clinics program tailored for type 1 diabetes care, harnessing cutting-edge Antibody Detection by Agglutination-PCR (ADAP) technology. This initiative aimed to transform early diabetes detection and management by providing clinics with a highly reliable testing tool, proven through rigorous, peer-reviewed studies, including impressive outcomes in the Islet Autoantibody Standardization Program evaluations. Endorsed by JDRF, the global player in type 1 diabetes research funding, this program underlines the significance of early diagnosis in leveraging new treatment advancements that can delay diabetes onset.

Key Company Profiles

The report delves into recent significant developments in the Glycated Albumin Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam PLC, Abnova Corporation, AFG Bioscience LLC, Asahi Kasei Corporation, Beijing Jiuqiang Biotechnology Co., Ltd., Biomatik Corporation, Cardinal Health, Inc., Crystal Chem Inc., Cusabio Technology LLC, Diazyme Laboratories, Inc., DxGen Corp., EKF Diagnostics Holdings, Epinex Diagnostics Inc., Hzymes Biotech, Laboratory Corporation of America Holdings, LifeSpan BioSciences, Inc., Merck KGaA, Novatein Biosciences Inc., Sekisui Chemical Co., Ltd., Thermo Fisher Scientific Inc., Thomas Scientific LLC, Weldon Biotech, Inc., and Wuhan Fine Biotech Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Glycated Albumin Assay Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diabetes worldwide
5.1.1.2. Government initiatives for early diabetes screening programs
5.1.2. Restraints
5.1.2.1. Technical limitations of glycated albumin testing
5.1.3. Opportunities
5.1.3.1. Advancements in technology for improved assay methodologies with enhanced accuracy and sensitivity
5.1.3.2. Growing development and use of point-of-care testing (POCT) of GA
5.1.4. Challenges
5.1.4.1. Limited awareness and presence of alternative techniques
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing use of animal glycated albumin assay to understand disease mechanisms
5.2.2. Application: Significant adoption of glycated albumin assay for detection of type 1 diabetes owing to prevent health complications
5.2.3. End User: High usage of glycated albumin assay in diagnostic laboratories
5.3. Market Trend Analysis
5.3.1. Rising incidences of diabetes, and robust healthcare sector in the Americas region
5.3.2. Exponential diabetes awareness programs improving the availability and preference for glycated albumin assay kits across the Asia-Pacific
5.3.3. Expanding availability of patents for glycated albumin assays with increasing healthcare expenditure in EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Glycated Albumin Assay Market, by Product
6.1. Introduction
6.2. Animal Glycated Albumin Assay
6.3. Human Glycated Albumin Assay
7. Glycated Albumin Assay Market, by Application
7.1. Introduction
7.2. Prediabetes
7.3. Type 1 Diabetes
7.4. Type 2 Diabetes
8. Glycated Albumin Assay Market, by End User
8.1. Introduction
8.2. Diabetic Care Centres
8.3. Diagnostic Laboratories
8.4. Hospitals & Clinics
9. Americas Glycated Albumin Assay Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Glycated Albumin Assay Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Glycated Albumin Assay Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Pioneering Partnership Between John Lewis and Randox Unveils In-Store Blood Testing to Enhance Health Diagnostics
12.3.2. Strategic Initiatives to Combat Diabetes and Hypertension in India
12.3.3. Advancing Type 1 Diabetes Care: Enable Biosciences Launches Innovative 'Kit to Clinics' Program Featuring ADAP Technology
12.3.4. Pioneering Innovations in Biotechnology: Recognizing the Achievements of WRCP IIT Faculty in Securing Biotechnology Ignition Grants
12.3.5. ELSA Study: Pioneering Early Detection and Management of Type 1 Diabetes in UK Children
12.3.6. Precision Diabetes, Inc. Partners with DxGen Corp. to Revolutionize Point-of-Care Diabetes Testing with the Launch of Epithod AutoDx
12.3.7. Introduction of the FDA-Cleared Lucica Glycated Albumin-L Test Kit by EKF Diagnostics
12.4. Strategy Analysis & Recommendation
12.4.1. Abcam PLC
12.4.2. Asahi Kasei Corporation
12.4.3. ??Cardinal Health, Inc.
12.4.4. Diazyme Laboratories, Inc.
12.4.5. EKF Diagnostics Holdings PLC
12.4.6. Epinex Diagnostics Inc.
12.4.7. Laboratory Corporation of America Holdings
12.4.8. Sekisui Chemical Co., Ltd.
12.4.9. Cusabio Technology LLC
12.4.10. Thermo Fisher Scientific Inc.
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. GLYCATED ALBUMIN ASSAY MARKET RESEARCH PROCESS
FIGURE 2. GLYCATED ALBUMIN ASSAY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLYCATED ALBUMIN ASSAY MARKET DYNAMICS
FIGURE 7. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. GLYCATED ALBUMIN ASSAY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. GLYCATED ALBUMIN ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GLYCATED ALBUMIN ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY ANIMAL GLYCATED ALBUMIN ASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY ANIMAL GLYCATED ALBUMIN ASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HUMAN GLYCATED ALBUMIN ASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HUMAN GLYCATED ALBUMIN ASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PREDIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIABETIC CARE CENTRES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIABETIC CARE CENTRES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 49. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 54. CANADA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 55. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 60. MEXICO GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 83. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 88. CHINA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 89. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 94. INDIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 101. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 106. JAPAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 137. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 142. THAILAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 162. DENMARK GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 163. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 168. EGYPT GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 169. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 174. FINLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 175. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 180. FRANCE GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 181. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 186. GERMANY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 193. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 198. ITALY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 211. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 216. NORWAY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 217. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 222. POLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 223. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 228. QATAR GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 247. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 252. SPAIN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 265. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 270. TURKEY GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM GLYCATED ALBUMIN ASSAY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 283. GLYCATED ALBUMIN ASSAY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. GLYCATED ALBUMIN ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abbexa Limited
  • Abcam PLC
  • Abnova Corporation
  • AFG Bioscience LLC
  • Asahi Kasei Corporation
  • Beijing Jiuqiang Biotechnology Co., Ltd.
  • Biomatik Corporation
  • Cardinal Health, Inc.
  • Crystal Chem Inc.
  • Cusabio Technology LLC
  • Diazyme Laboratories, Inc.
  • DxGen Corp.
  • EKF Diagnostics Holdings
  • Epinex Diagnostics Inc.
  • Hzymes Biotech
  • Laboratory Corporation of America Holdings
  • LifeSpan BioSciences, Inc.
  • Merck KGaA
  • Novatein Biosciences Inc.
  • Sekisui Chemical Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Thomas Scientific LLC
  • Weldon Biotech, Inc.
  • Wuhan Fine Biotech Co., Ltd.

Methodology

Loading
LOADING...

Table Information